DocWire News Editors

DocwireNews

<h2><a href="https://www.docwirenews.com/conference-coverage/asco2022/asco-metastatic-breast-cancer/addition-of-ribociclib-to-endocrine-therapy-improves-survival-in-metastatic-breast-cancer/">Addition of Ribociclib to Endocrine Therapy Improves Survival in Metastatic Breast Cancer</a><p>Ribociclib plus endocrine therapy led to a statistically significant improvement in PFS compared with placebo plus endocrine therapy in participants with tumor progression following a CDK 4/6 inhibitor</p><h2><a href="https://www.docwirenews.com/conference-coverage/asco2022/asco-metastatic-breast-cancer/investigational-treatment-combo-produces-responses-in-her2-positive-metastatic-breast-cancer/">Investigational Treatment Combo Produces Responses in HER2-Positive Metastatic Breast Cancer</a></h2><p>Pyrotinib, a second-generation, irreversible anti-human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitor, plus nab-paclitaxel showed promising anti-tumor activity in patients with HER2-positive advanced or metastatic breast cancer.</p><h2><a href="https://www.docwirenews.com/conference-coverage/asco2022/asco-metastatic-breast-cancer/practice-changing-results-seen-with-targeted-therapy-in-her2-low-metastatic-breast-cancer/">&ldquo;Practice-Changing&rdquo; Results Seen With Targeted Therapy in HER2-Low Metastatic Breast Cancer</a></h2><p>Results of the DESTINY-Breast04 study, presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, demonstrated significant survival benefit with trastuzumab deruxtecan versus standard of care chemotherapy in patients with human epidermal growth factor receptor 2 (HER2)-low metastatic breast cancer.</p><h2 class="entry-title"><a href="https://www.docwirenews.com/conference-coverage/asco2022/asco-metastatic-breast-cancer/these-factors-predict-survival-in-patients-with-her2-positive-breast-cancer-and-brain-metastases/">These Factors Predict Survival in Patients With HER2-Positive Breast Cancer and Brain Metastases</a></h2><p>Research presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting revealed prognostic factors that impacted overall survival (OS) in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer and brain metastases</p><h2><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/sunitinib-as-second-line-metastatic-renal-cell-carcinoma-treatment/">Sunitinib as Second-Line Metastatic Renal Cell Carcinoma Treatment</a></h2><p>In&nbsp;<em>ESMO Open</em>, Enrique Grande, MD, and collaborating researchers published findings from the IMMUNOSUN trial on the safety and efficacy of sunitinib as a pure second-line treatment for patients with metastatic&nbsp;renal cell carcinoma (mRCC).</p></h2>


Areef Ishani, MD

Joel M. Topf, MD, FACP

Kidney Stones With Chlorthalidone Versus Hydrochlorothiazide

NKF Spring Clinical Meetings 2025

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Seldin Award Winner Advocates Online Education

Latest News

Oncology Round-Up: Ribociclib, "Unheard of" Response in Breast Cancer; and More

Oncology

Addition of Ribociclib to Endocrine Therapy Improves Survival in Metastatic Breast Cancer ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe